MicroRNAs as a possible biomarker in the treatment of multiple sclerosis

Multiple sclerosis (MS) is a demyelinating, autoimmune and inflammatory disease that affects the central nervous system (CNS) and is one of the leading causes of disability in young adults worldwide. There are different drugs for the treatment of MS that aim to modify the natural course of the disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez, Moisés Manuel Gallardo, Eisele, Solón Javier Garcés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685387/
https://www.ncbi.nlm.nih.gov/pubmed/36439971
http://dx.doi.org/10.1016/j.ibneur.2022.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685387/
https://www.ncbi.nlm.nih.gov/pubmed/36439971
http://dx.doi.org/10.1016/j.ibneur.2022.11.001

Ejemplares similares